Tag: physical sciences
-
Technique Developed for High-Speed Antibody Screening
A process is being developed to quickly discover antibodies in a person’s immune system that can also lead to new vaccines and drugs against viruses.
-
Little Data to Support Wearable Device Health Benefits
A review of published research since 2000 shows little evidence to support claims of beneficial health outcomes from the use of wearable devices like smart watches or wristbands, at least not yet.
-
Nerve Stimulation Shown to Reduce Diabetes Symptoms
Electric stimulation of a key nerve pathway was shown in lab animals to restore insulin sensitivity and glucose tolerance typically missing in people with type 2 diabetes.
-
Components Designed to Improve Genetic Circuits
Researchers in Houston, Texas created a set of components like those in electronics that help make synthetic gene circuits more accurate and predictable.
-
Neuro Informatics Software Released to Open Source
A collection of software from the Blue Brain Project for reconstructing models of mammal brain circuitry is being made freely available to the research community.
-
HIV Drugs Formulated Into Once-Weekly Capsules
Medical and engineering researchers developed and tested in pigs a technique for packing several drugs into a capsule taken once a week to prevent and treat HIV infections.
-
Lilly, Tech Company Study Diabetes Experiences
A maker of diabetes drugs and digital health enterprise are beginning a study of real world experiences with self-management and education among people with diabetes.
-
Continuous Flow Manufacturing In Space Station Test
Among the experiments carried to the International Space Station in mid-December is a test of continuous separations of one liquid from another, used in drug and chemical manufacturing.
-
Biotech, Microsoft Partner on Immune System Diagnostics
A company that analyzes immune system genomics is collaborating with Microsoft Corporation to develop early-stage disease diagnostics.
-
RNA Therapies Start-Up Raises $55.3M in Early Funds
A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round.